The Role of Ribosomal RNA Modifications
The Role of Ribosomal RNA Modifications
批准号:
8225288
负责人:
Christine S Chow
金额:
$28.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2015-02-28
关键词:
2-AminopurineAddressAffinityAmino AcidsAnti-Bacterial AgentsAntibiotic ResistanceAppearanceAreaBacteriaBacterial RNABase SequenceBindingBinding SitesBiochemicalBiologicalBiological AssayBiological ModelsBiophysicsChemicalsCircular DichroismCisplatinComplexDevelopmentDrug Delivery SystemsDrug InteractionsDrug resistanceEscherichia coliFluorescenceFluorescence SpectroscopyGeneticGoalsHealthHumanIn VitroIndividualKineticsLabelLeadLengthLifeLigandsLiteratureLocationMapsMethodsModelingModificationMolecularMolecular ConformationMonitorNMR SpectroscopyNormal CellNucleic AcidsNucleosidesNucleotidesOrganic SynthesisOrganismPeptidesPhage DisplayPharmaceutical PreparationsPlatinumPlayPropertyProtein BiosynthesisProteinsPseudouridineRNA, Ribosomal, 23SRNA, Ribosomal, 28SReactionReagentRegulationReportingResearchResolutionRibosomal RNARibosomesRoentgen RaysRoleSamplingSiteSpecificityStructureStructure-Activity RelationshipSystemTechniquesTechnologyTestingTherapeuticTranslatingTranslationsVariantWorkanalogbacterial resistancebasecell growthdesigndimethyl sulfatein vivonovelpathogenic bacteriaprotein aminoacid sequenceprotonationpublic health relevancethree dimensional structureviral RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A study of site-specific modifications in ribosomal RNA (rRNA) is proposed in which a combination of synthetic, biophysical, and biological approaches will be taken. The long-term goal of the work is to understand the significance of modified nucleotides in rRNA and their roles in regulation of ribosome function, namely translation. The design of novel rRNA-targeting drugs as potential antibacterials will ultimately rely on a fundamental understanding of rRNA structure- function relationships. The short-term goals of the proposed project are to obtain detailed information regarding the roles of pseudouridine and its analogues in regulating ribosome conformation changes and dynamics as they relate to protein synthesis. Modified RNAs representing the exposed hairpin in domain IV of the bacterial large subunit rRNAs (helix 69) will be synthesized and characterized by various biophysical techniques. Preliminary studies revealed sequence and structural differences between human and bacterial H69 RNAs, and literature reports indicate that H69 is essential for normal ribosome function, making this region of the ribosome an ideal drug-targeting site. The specific aims of the research plan are to: 1) characterize the conformational switching mechanism in H69 in humans and bacteria through a variety of biophysical studies (NMR, circular dichroism, fluorescence spectroscopy), 2) use chemical probing and biological assays on full-length ribosomal RNAs and ribosomes to reveal whether structural changes observed in model systems are relevant in natural systems, and 3) identify and characterize ligands that have specificity for bacterial helix 69 over the human variant, and can selectively inhibit bacterial ribosome function. Together these aims combine the strengths of multiple areas of research (organic synthesis, RNA modification, RNA biophysics, and chemical probing) t address key issues that will impact human health and defense against resistant bacteria.
PUBLIC HEALTH RELEVANCE: The protein synthesis machinery, the ribosome, is essential to all living organisms, and catalyzes key steps in translating genetic information stored in the form of a nucleic acid to a functionally important protein. This machine depends on precise molecular interactions in order to maintain fidelity and carry out its function essentially without errors. The pseudouridine modification, which is abundant in ribosomal RNA, plays a key role in maintaining such fidelity. One region containing conserved pseudouridine modifications, helix 69, is essential for normal cell growth. The exact roles of pseudouridine in regulating ribosome function are currently unknown. The aims of this proposal are to elucidate the molecular and physical basis for helix 69 dynamics and function, and to determine key differences between human and bacterial ribosome structure and function. This information will be used to design and select for ligands that selectively target bacterial ribosomes, and could lead to the development of potential therapeutics for drug-resistant and/or pathogenic bacteria, thus having an impact on human health.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Pseudouridine modifications influence binding of aminoglycosides to helix 69 of bacterial ribosomes.
DOI:
10.1039/c7ob02147j
发表时间:
2017-10-18
期刊:
Organic & biomolecular chemistry
影响因子:
3.2
作者:
[Sakakibara Y, Chow CS]
通讯作者:
Chow CS
Modulation of conformational changes in helix 69 mutants by pseudouridine modifications.
通过假尿苷修饰调节螺旋 69 突变体的构象变化。
DOI:
10.1016/j.bpc.2015.03.001
发表时间:
2015-05
期刊:
BIOPHYSICAL CHEMISTRY
影响因子:
3.8
作者:
[Jiang, Jun, Kharel, Daya Nidhi, Chow, Christine S.]
通讯作者:
Chow, Christine S.
The development of peptide ligands that target helix 69 rRNA of bacterial ribosomes.
开发针对细菌核糖体螺旋 69 rRNA 的肽配体。
DOI:
10.1016/j.bmc.2016.07.050
发表时间:
2016
期刊:
Bioorganic & medicinal chemistry
影响因子:
3.5
作者:
[Dremann,DanielleN, Chow,ChristineS]
通讯作者:
Chow,ChristineS
Cisplatin Targeting of Bacterial Ribosomal RNA Hairpins.
顺铂靶向细菌核糖体 RNA 发夹。
DOI:
10.3390/ijms160921392
发表时间:
2015
期刊:
International journal of molecular sciences
影响因子:
5.6
作者:
[Dedduwa-Mudalige,GayaniNP, Chow,ChristineS]
通讯作者:
Chow,ChristineS
Chemistry Biology Interface Training Program at Wayne State University
-
批准号:10416043
-
项目类别:
-
资助金额:$23.61万
-
财政年份:2021
-
负责人:Christine S Chow
-
依托单位:
Chemistry Biology Interface Training Program at Wayne State University
-
批准号:10269129
-
项目类别:
-
资助金额:$17.58万
-
财政年份:2021
-
负责人:Christine S Chow
-
依托单位:
IMSD at Wayne State University
-
批准号:10090813
-
项目类别:
-
资助金额:$50.34万
-
财政年份:2021
-
负责人:Christine S Chow
-
依托单位:
Chemistry Biology Interface Training Program at Wayne State University
-
批准号:10620216
-
项目类别:
-
资助金额:$24.12万
-
财政年份:2021
-
负责人:Christine S Chow
-
依托单位:
Training Modules at Wayne State University to Promote Safe and Inclusive Environments
-
批准号:10393898
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2021
-
负责人:Christine S Chow
-
依托单位:
Wayne State University - Broadening Experiences in Scientific Training (BEST)
-
批准号:9133483
-
项目类别:
-
资助金额:$34.69万
-
财政年份:2013
-
负责人:Christine S Chow
-
依托单位:
The Role of Ribosomal RNA Modifications
-
批准号:8037133
-
项目类别:
-
资助金额:$28.25万
-
财政年份:2009
-
负责人:Christine S Chow
-
依托单位:
The Role of Ribosomal RNA Modifications
-
批准号:7786247
-
项目类别:
-
资助金额:$28.58万
-
财政年份:2009
-
负责人:Christine S Chow
-
依托单位:
Single Molecule Study of Spliceosomal RNAs
-
批准号:8266517
-
项目类别:
-
资助金额:$26.5万
-
财政年份:2008
-
负责人:Christine S Chow
-
依托单位:
Purchase of a MALDI-TOF Mass Spectrometer
-
批准号:6440944
-
项目类别:
-
资助金额:$25.98万
-
财政年份:2002
-
负责人:Christine S Chow
-
依托单位:
SITE SPECIFICALLY MODIFIED RNAS
-
批准号:2883044
-
项目类别:
-
资助金额:$10.21万
-
财政年份:1997
-
负责人:Christine S Chow
-
依托单位:
A Study of Site-Specifically Modified RNAs
-
批准号:6986178
-
项目类别:
-
资助金额:$21.57万
-
财政年份:1997
-
负责人:Christine S Chow
-
依托单位:
SITE SPECIFICALLY MODIFIED RNAS
-
批准号:2668529
-
项目类别:
-
资助金额:$9.82万
-
财政年份:1997
-
负责人:Christine S Chow
-
依托单位:
SITE SPECIFICALLY MODIFIED RNAS
-
批准号:6164804
-
项目类别:
-
资助金额:$10.62万
-
财政年份:1997
-
负责人:Christine S Chow
-
依托单位:
A Study of Site-Specifically Modified RNAs
-
批准号:6572739
-
项目类别:
-
资助金额:$25.85万
-
财政年份:1997
-
负责人:Christine S Chow
-
依托单位:
A Study of Site-Specifically Modified RNAs
-
批准号:6830234
-
项目类别:
-
资助金额:$22.11万
-
财政年份:1997
-
负责人:Christine S Chow
-
依托单位:
SITE SPECIFICALLY MODIFIED RNAS
-
批准号:6363275
-
项目类别:
-
资助金额:$11.04万
-
财政年份:1997
-
负责人:Christine S Chow
-
依托单位:
A Study of Site-Specifically Modified RNAs
-
批准号:6687762
-
项目类别:
-
资助金额:$22.14万
-
财政年份:1997
-
负责人:Christine S Chow
-
依托单位:
SITE SPECIFICALLY MODIFIED RNAS
-
批准号:2023477
-
项目类别:
-
资助金额:$9.44万
-
财政年份:1997
-
负责人:Christine S Chow
-
依托单位:
CISPLATIN DAMAGE RECOGNITION PROTEIN
-
批准号:2085100
-
项目类别:
-
资助金额:$1.58万
-
财政年份:1994
-
负责人:Christine S Chow
-
依托单位:
海外基金